|
|
||||||||
The Journal of Immunology, Vol 156, Issue 2 818-825, Copyright © 1996 by American Association of Immunologists
ARTICLES |
K Daw, N Ujihara, M Atkinson and AC Powers
Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA.
Glutamic acid decarboxylase (GAD) is an autoantigen in two autoimmune diseases, insulin-dependent diabetes mellitus (IDDM) and stiff-man syndrome (SMS). However, most individuals with one of these diseases do not have the other disease. Prior studies have suggested that the natures of the GAD Abs associated with each of these diseases are different, which may have implications for the autoimmune pathogenesis. We have compared the GAD autoantibody profile and have mapped GAD protein epitope regions in the two diseases using an immunoprecipitation assay with recombinant GAD 65 and GAD 67 proteins, GAD protein fragments, and synthetic GAD peptides, as well as chimeric GAD proteins. Our results indicate that individuals with SMS have GAD Abs in 100- to 500-fold higher titer than individuals with IDDM. The population of GAD Abs in SMS sera is quite complex and includes those that recognize at least three GAD 65 epitope regions located between amino acids 1-16, 188-442, and 442-563. These types of GAD Abs are not found in IDDM sera. All SMS sera also had Ab specificity that binds GAD 67 in a region highly homologous to amino acids 188-442 of GAD 65. In contrast to prior studies that used immunoblotting to measure GAD Abs, we find GAD Abs in SMS sera also target two conformation-dependent regions of GAD 65, one located in the middle and one near the C- terminus of the protein. These two regions of the GAD 65 protein are similar to regions targeted by GAD 65-specific Abs found in individuals with IDDM. These results indicate that although disease-specific epitopes may exist, there is also overlap in the humoral response between the two diseases.
This article has been cited by other articles:
![]() |
A. Saiz, Y. Blanco, L. Sabater, F. Gonzalez, L. Bataller, R. Casamitjana, L. Ramio-Torrenta, and F. Graus Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association Brain, August 7, 2008; (2008) awn183v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Lee, H. Lee, J.-S. Park, H. Choi, K.-Y. Han, H.-S. Seo, K.-Y. Ahn, S.-S. Han, Y. Cho, K.-H. Lee, et al. A novel approach to ultrasensitive diagnosis using supramolecular protein nanoparticles FASEB J, May 1, 2007; 21(7): 1324 - 1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Vulliemoz, G Vanini, A Truffert, C Chizzolini, and M Seeck Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies J. Neurol. Neurosurg. Psychiatry, February 1, 2007; 78(2): 187 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Raju, J. Foote, J. P. Banga, T. R. Hall, C. J. Padoa, M. C. Dalakas, E. Ortqvist, and C. S. Hampe Analysis of GAD65 Autoantibodies in Stiff-Person Syndrome Patients J. Immunol., December 1, 2005; 175(11): 7755 - 7762. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maioli, E. Alejandro, G. Tonolo, L. K. Gilliam, L. Bekris, C. S. Hampe, D. A. Obinu, A. Manconi, L. Puddu, K. Lynch, et al. Epitope-Restricted 65-Kilodalton Glutamic Acid Decarboxylase Autoantibodies among New-Onset Sardinian Type 2 Diabetes Patients Define Phenotypes of Autoimmune Diabetes J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5675 - 5682. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Padoa, J. P. Banga, A.-M. Madec, M. Ziegler, M. Schlosser, E. Ortqvist, I. Kockum, J. Palmer, O. Rolandsson, K. A. Binder, et al. Recombinant Fabs of Human Monoclonal Antibodies Specific to the Middle Epitope of GAD65 Inhibit Type 1 Diabetes-Specific GAD65Abs Diabetes, November 1, 2003; 52(11): 2689 - 2695. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Dalakas, M. Fujii, M. Li, B. Lutfi, J. Kyhos, and B. McElroy High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome N. Engl. J. Med., December 27, 2001; 345(26): 1870 - 1876. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rickert, J. Seissler, W. Dangel, H. Lorenz, and W. Richter Fusion Proteins for Combined Analysis of Autoantibodies to the 65-kDa Isoform of Glutamic Acid Decarboxylase and Islet Antigen-2 in Insulin-dependent Diabetes Mellitus Clin. Chem., May 1, 2001; 47(5): 926 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Honnorat, A. Saiz, B. Giometto, A. Vincent, L. Brieva, C. de Andres, J. Maestre, N. Fabien, A. Vighetto, R. Casamitjana, et al. Cerebellar Ataxia With Anti-Glutamic Acid Decarboxylase Antibodies: Study of 14 Patients Arch Neurol, February 1, 2001; 58(2): 225 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Dalakas, M. Fujii, M. Li, and B. McElroy The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome Neurology, November 28, 2000; 55(10): 1531 - 1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Falorni, G. Gambelunghe, F. Forini, G. Kassi, A. Cosentino, P. Candeloro, G. B. Bolli, P. Brunetti, and F. Calcinaro Autoantibody Recognition of COOH-Terminal Epitopes of GAD65 Marks the Risk for Insulin Requirement in Adult-Onset Diabetes Mellitus J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 309 - 316. [Abstract] [Full Text] |
||||
![]() |
L. M. Levy, M. C. Dalakas, and M. K. Floeter The Stiff-Person Syndrome: An Autoimmune Disorder Affecting Neurotransmission of {gamma}-Aminobutyric Acid Ann Intern Med, October 5, 1999; 131(7): 522 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Hampe, E. Örtqvist, O. Rolandsson, M. Landin-Olsson, C. Törn, A. Ågren, B. Persson, D. B. Schranz, and A. Lernmark Species-Specific Autoantibodies in Type 1 Diabetes J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 643 - 648. [Abstract] [Full Text] |
||||
![]() |
R A Barker, T Revesz, M Thom, C D Marsden, and P Brown Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity J. Neurol. Neurosurg. Psychiatry, November 1, 1998; 65(5): 633 - 640. [Abstract] [Full Text] |
||||
![]() |
J. Tremble, N. G. Morgenthaler, A. Vlug, A. C. Powers, M. R. Christie, W. A. Scherbaum, and J. P. Banga Human B Cells Secreting Immunoglobulin G to Glutamic Acid Decarboxylase-65 from a Nondiabetic Patient with Multiple Autoantibodies and Graves' Disease: A Comparison with Those Present in Type 1 Diabetes J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2664 - 2670. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Slover and G. S. Eisenbarth Prevention of Type I Diabetes and Recurrent {beta}-Cell Destruction of Transplanted Islets Endocr. Rev., April 1, 1997; 18(2): 241 - 258. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |